Alleima has decided to establish a production footprint for its medical business in Asia by opening a new facility in Penang, Malaysia. This will further strengthen the company’s medical wire manufacturing capacity.
The new production facility will enable Alleima to capture opportunities from the growing demand in the region by increased capacity and improved manufacturing flexibility, staying close to customers. Site preparations will start at the end of 2024, with first commercial deliveries in 2026.
Penang, Malaysia, is a growing Asian hub for medical companies. Furthermore, the Asian region is the fastest growing market for medical devices in the world because of its aging population, adoption of advanced medical technologies and other economic growth drivers.
“This footprint expansion in Asia will be an important foundation to support our long-term strategy to grow our medical business. Demand for our products is growing at a high pace, and the new footprint will allow us to better collaborate and serve both new and existing customers in region,” says Robert Stål, president of Alleima’s Kanthal division.
Alleima’s ultra-fine medical wire is used in applications in various fields of medical technology, such as remote patient monitoring, vascular therapy, sensing and neurostimulation, where innovative and high-quality solutions are developed in close collaboration with partners.
The facility will be governed within the Kanthal division of Alleima, which currently has production of medical products in Europe and the US.